Results 21 to 30 of about 10,553 (193)
A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy. [PDF]
, 2017 peer reviewedOBJECTIVE: To conduct a randomized trial to test the primary hypothesis that once-daily tadalafil, administered orally for 48 weeks, lessens the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD).Wolfgang Mueller-Felber, Tadalafil DMD Study Group, Susan Iannaccone, Pereon, Yann, Russell Butterfield, Dubrovsky, A.L., Finkel, Richard, Schallner, Jens, Cox, D., Haluk Topaloglu, Susan Sparks, Finkel, R., Butterfield, Russell, Dubrovsky, Alberto AL, Cox, David A., Victor RG, null null, Vandenborne, Krista, Saleel Chandratre, Ben Renfroe, Belousova, Elena, Selby, Kathryn, Mcdonald, Craig M, Dooley, Joseph, Claudio Bruno, Robert Elashoff, Chae, Jong-Hee, Pat Furlong, Jean Mah, Anne Connolly, Susan Apkon, McDonald, C.M., Sparks, Susan, Michelle Eagle, de Munain, Adolfo Lopez, Kirschner, JanBerd, McDonald, Craig M., Cox David, Hattori, Ayako, Eagle M, Giacomo Comi, Wilichoswki, Ekkehard, Victor, R.G., Wang-Tso Lee, Janas, Joanne, Sendra, Isabel Illa, Elashoff, Robert, Dubrovsky, Alberto, Hoda Abdel-Hamid, McDonald, Craig, Sanka, Ratna Bhavaraju, Miceli, Carrie MC, Enrico Bertini, Eagle, M., Dubrovsky AL, Jong-Hee Chae, Katherine Mathews, JanBerd Kirschner, Katsuhisa Ogata, Finkel, Richard S., Miceli, MC, Matthew Wicklund, Sweeney HL, Finkel, Richard RS, John Landry, Yuh-Jyh Jong, Bertini, Enrico, McDonald CM, Sweeney, H. Lee, Sweeney, Lee HL, Landry J, Kuntz, Nancy, Group, Tadalafil DMD Study, Harper, Amy, Kathryn Selby, Campbell, Craig, Pascual, Samuel, Connolly, Anne, Elashoff R, Hirofumi Komaki, Edward Smith, William Burnette, Tadalafil DMD Study Grp, Bruno, Claudio, Mueller-Felber, Wolfgang, Topaloglu H, Victor, Ronald G, Vandenborne K, Miceli, M. Carrie, Erik Niks, Sweeney, H.L., Eugenio Mercuri, Burnette, William, Lee, Wang-Tso, David Cox, Victor, Ron, Cox, David, Isabel Illa Sendra, Jong, Yuh-Jyh, H. Lee Sweeney, Furlong P, McMillan, Hugh, Dubrovsky, Alberto L, Jose Carlo, Juan Jose Vilchez, Carlo, Jose, Vilchez, Juan Jose, Jens Schallner, Krista Vandenborne, Goemans N, Renfroe, Ben, Mah, Jean, Victor, Ronald G., Joanne Janas, Craig McDonald, Hugh McMillan, Joseph Dooley, Richard Finkel, Finkel R, Sweeney, H Lee, Nicolas Deconinck, Ronald G. Victor, Byrne B, De Groot, Imelda, Herguner, Ozlem, Goemans, Nathalie, Wong, Brenda, Iannaccone, Susan, Dubrovsky, Alberto L., Comi, Giacomo, Ozlem Herguner, Imelda De Groot, Adolfo Lopez de Munain, Schara, Ulrike, Eagle, Michelle, Mathews, Katherine, Edward Leung, Elena Pegoraro, Frank, L Matthew, Leung, Edward, Tadalafil DMD Study Group,, Landry, John, Cox D, Ogata, Katsuhisa, Wicklund, Matthew, Pegoraro, Elena, Miceli, M Carrie, Laurent Servais, Barry Byrne, Byrne, B., Topaloglu, H., John Brandsema, Samuel Pascual, Yann Pereon, Niks, Erik, Brandsema, John, Ulrike Schara, Landry, J., Servais, Laurent, Byrne, Barry, Elashoff, Robert M., Barohn, Richard, Tadalafil DMD, [Study group], Craig M. McDonald, Elashoff, R., Akinori Nakamura, Mercuri, Eugenio, Amy Harper, Ratna Bhavaraju Sanka, L Matthew Frank, Julien Durigneux, Nancy Kuntz, Abdel-Hamid, Hoda, Nakamura, Akinori, Ayako Hattori, Nathalie Goemans, Deconinck, Nicolas, Ron Victor, Alberto L. Dubrovsky, Goemans, N., Ekkehard Wilichoswki, Miceli MC, Miceli, M.C., Richard Barohn, Apkon, Susan, Alberto Dubrovsky, Elena Belousova, Durigneux, Julien, Topaloglu, Haluk, Smith, Edward, Vandenborne, K., Furlong, Pat, Craig Campbell, Furlong, P., Chandratre, Saleel, M. Carrie Miceli, Komaki, Hirofumi, Brenda Wong, Finanger, Erika, Erika Finanger +199 morecore +6 more sourcesTadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.
, 2011 Background: Tadalafil 40 mg orally once daily, was shown to be well-tolerated and efficacious for pulmonary arterial hypertension in a 16-week, double-blind, placebo (PBO)-controlled trial.Simonneau G, Oudiz RJ, Brundage BH, Response to Tadalafil Study Group, Beardsworth A, Ghofrani HA, Barst RJ, Sundin DP, Pulmonary Arterial Hypertension, GALIE', NAZZARENO +9 morecore +2 more sourcesTadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice. [PDF]
PLoS ONE, 2016 We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice.Lei Wang, Michael Chopp, Alexandra Szalad, XueRong Lu, LongFei Jia, Mei Lu, Rui Lan Zhang, Zheng Gang Zhang +7 moredoaj +1 more sourceMeta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction
Sexual Medicine, 2019 Background: Erectile dysfunction (ED) is highly prevalent in aging men. Tadalafil daily and on-demand are widely used for the treatment of ED. Aim: We performed a meta-analysis to evaluate the efficacy and safety of tadalafil daily compared with ...Zhongbao Zhou, MM, Hongyan Chen, MM, Jitao Wu, MD, Jipeng Wang, MM, Xuebao Zhang, MM, Jiajia Ma, MM, Yuanshan Cui, MD +6 moredoaj +1 more sourceEndothelial Dysfunction in Patients With Erectile Dysfunction: A Double-Blind, Randomized-Control Trial Using Tadalafil
Sexual Medicine, 2019 Objective: To assess whether tadalafil improves endothelial dysfunction(EnD) in a placebo-controlled randomized-control trial. Methods: Erectile dysfunction and EnD were assessed by the International Index of Erectile Function (IIEF-5) and flow-mediated ...Smita Pattanaik, DM, Pawan Kaundal, MS, Ravimohan S. Mavuduru, MCh, Shrawan K. Singh, MCh, Arup K. Mandal, MCh +4 moredoaj +1 more source